HYPR Hyperfine receives FDA clearance for Next Optive AI software
HYPR Hyperfine announces FDA clearance for its Next Optive AI software, describing further enhancements to image quality, clinical utility, and ease of use for the Swoop system across care settings.
Story updates
12:16:07 PM UTC
SquawkNews
HYPR Hyperfine announces FDA clearance of the next optive ai™ software, further enhancing Image quality, clinical utility, and ease of use of the swoop® system across Care settings Hyperfine, - to begin U.S. rollout of new software in September
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.